BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL
12121 results:

  • 1. Demographical and Epidemiological Contribution to cancer Incidence in Delhi and Its Trends from 1991-2015.
    Malhotra RK; Manoharan N; Deo SS; Bhatnagar S
    Asian Pac J Cancer Prev; 2024 Apr; 25(4):1213-1222. PubMed ID: 38679980
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence.
    Tamburo M; Buffettino E; Pepe P; Marletta G; Pepe L; Cosentino S; Ippolito M; Pennisi M; Marletta F
    Anticancer Res; 2024 May; 44(5):2205-2210. PubMed ID: 38677723
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. [prostate cancer - a disease in transformation].
    Bratt O
    Lakartidningen; 2024 Apr; 121():. PubMed ID: 38661575
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Antibacterial prophylaxis with fosfomycin at the time of the urethral catheter removal after radical prostatectomy (prospective randomized trial)].
    Veliev E I; Sokolov E A; Metelev A Y; Aliev E N; Polyakova A S; Ivkin E V
    Urologiia; 2024 Mar; (1):35-40. PubMed ID: 38650404
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Surgical management of rectal cancer with synchronous treatment of prostate cancer.
    Brière R; Martin AG; Letarte F; Fournier FR; Bouchard P; Drolet S
    Langenbecks Arch Surg; 2024 Apr; 409(1):133. PubMed ID: 38642125
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of Care for Medicare Beneficiaries With Metastatic prostate cancer.
    Filson CP; Richards TB; Ekwueme DU; Howard DH
    Urol Pract; 2024 May; 11(3):489-497. PubMed ID: 38640419
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transcriptome-Based Prognostic and Predictive Biomarker Analysis of ENACT: A Randomized Controlled Trial of Enzalutamide in Men Undergoing Active Surveillance.
    Ross AE; Iwata KK; Elsouda D; Hairston J; Russell D; Davicioni E; Proudfoot JA; Shore ND; Schaeffer EM
    JCO Precis Oncol; 2024 Apr; 8():e2300603. PubMed ID: 38635932
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Individualized center-based analysis of urinary and sexual functional outcome after radical prostatectomy based on the prostate cancer outcome study: a post hoc pathway to patient outcome measurement analysis for quality improvement.
    Duwe G; Boehm K; Becker G; Ruckes C; Sparwasser P; Haack M; Dotzauer R; Thomas A; Mager R; Tsaur I; Neumann CCM; Feick G; Carl G; Brandt MP; Haferkamp A; Höfner T
    World J Urol; 2024 Apr; 42(1):236. PubMed ID: 38619659
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Non-preventable cases of breast, prostate, lung, and colorectal cancer in 2050 in an elimination scenario of modifiable risk factors.
    Palshof FK; Mørch LS; Køster B; Engholm G; Storm HH; Andersson TM; Kroman N
    Sci Rep; 2024 Apr; 14(1):8577. PubMed ID: 38615059
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [A single center study:An analysis of the safety and validity of delaying repeated biopsy for patients with atypical small acinar proliferation].
    Ji WT; Liu DC; Cui WL; Hu Y; Wang Y; Tan JF
    Zhonghua Nan Ke Xue; 2023 May; 29(5):414-419. PubMed ID: 38602757
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Erectile function preservation after radiotherapy using a dose-optimization approach on sexual structures for localized prostate cancer.
    Chardon A; Udrescu C; Beneux A; Ruffion A; Horn S; Lapierre A; Chapet O
    Cancer Radiother; 2024 Apr; 28(2):182-187. PubMed ID: 38599939
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical safety and efficacy of microwave ablation for small renal masses.
    Foret A; Haaga CB; Jain S; Baumgartner CO; Escott M; Henderson BR; O'Brien ST; Delacroix SE; Gills JRR; Westerman ME
    Int Braz J Urol; 2024; 50(3):277-286. PubMed ID: 38598830
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Assessment of the accuracy of biparametric MRI/TRUS fusion-guided biopsy for index tumor evaluation using postoperative pathology specimens.
    Shimizu R; Morizane S; Yamamoto A; Yamane H; Nishikawa R; Kimura Y; Yamaguchi N; Hikita K; Honda M; Takenaka A
    BMC Urol; 2024 Apr; 24(1):79. PubMed ID: 38575912
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Development, synthesis and validation of improved c-Myc/Max inhibitors.
    Yıldırım S; Kocabaş F; Mermer A
    J Cell Mol Med; 2024 Apr; 28(8):e18272. PubMed ID: 38568057
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Population-based BRCA germline mutation screening in the Han Chinese identifies individuals at risk of BRCA mutation-related cancer: experience from a clinical diagnostic center from greater Shanghai area.
    Wu Z; Zhang Q; Jin Y; Zhang X; Chen Y; Yang C; Tang X; Jiang H; Wang X; Zhou X; Yu F; Wang B; Guan M
    BMC Cancer; 2024 Apr; 24(1):411. PubMed ID: 38566028
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. prostate-Specific Antigen Screening in Smokers: A Comprehensive Analysis Using a National Behavioral Survey.
    Harmatz IM; Alkhatib KY; Leff M; Nolazco JI; Michel KF; Slinger M; McLauchlan N; Cortese BD; Roberson DS; Schurhamer B; Lee DJ; Malkowicz SB; Trinh QD; Bivalacqua TJ; Guzzo TJ; Pierorazio PM
    Urol Pract; 2024 May; 11(3):547-556. PubMed ID: 38564816
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Combination of prostate volume and apparent diffusion coefficient can stratify patients with a PI-RADS score of 3 to reduce unnecessary prostate biopsies.
    Dong Q; Wang C; Shen D; Ma Y; Zhang B; Xu S; Tao T; Xiao J
    Prostate; 2024 Jun; 84(8):780-787. PubMed ID: 38558415
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The treatment landscape of nonmetastatic castrate resistant prostate cancer: A contemporary perspective.
    Yanada BA; Homewood D; Dias BH; Ogluszko C; Corcoran NM
    Urol Oncol; 2024 Jun; 42(6):175.e9-175.e18. PubMed ID: 38555235
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany.
    Rühle A; Wieland L; Hinz A; Mehnert-Theuerkauf A; Nicolay NH; Seidel C
    J Cancer Res Clin Oncol; 2024 Mar; 150(3):167. PubMed ID: 38546873
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A
    Abu Shtaya A; Kedar I; Bazak L; Basel-Salmon L; Barhom SF; Naftali M; Eskin-Schwartz M; Birk OS; Polager-Modan S; Keidar N; Reznick Levi G; Levi Z; Yablonski-Peretz T; Mahamid A; Segol O; Matar R; Bareli Y; Azoulay N; Goldberg Y
    Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540414
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 607.